Clinical trial
Safety and Immunogenicity of Oxford AstraZeneca Vaccine in Zagazig University Hospital Health-care Workers
NCT04756271 is registered in ClinicalTrials.gov with Zagazig University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Immunogenicity of Oxford AstraZeneca Vaccine in Zagazig University Hospital Health-care Workers
- Lead sponsor
- Zagazig University
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- February 11, 2021
- Completion date
- December 22, 2021
- Enrollment
- 246 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
seroconversion, vaccine adverse reaction